Key signaling pathways regulate the biological activities and accumulation of amyloid-β

Neurobiology of Aging

Volumn 22, Issue 6, 2001, Pages 967-973

  Wyss Coray, Tony ^a   McConlogue, Lisa ^b   Kindy, Mark ^c   Schmidt, Ann Marie ^d   Du Yan, Shi ^d   Stern, David M ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ELAN PHARMACEUTICALS   (United States)

^c LEXINGTON VA MEDICAL CENTER   (United States)

^d College of Physicians and Surgeons of Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SERUM AMYLOID A; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ALZHEIMER DISEASE; ARTICLE; HUMAN; INFLAMMATION; NONHUMAN; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; INFLAMMATION; SIGNAL TRANSDUCTION;

EID: 0035690877     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00305-0     Document Type: Article

References (73)

1. Inflammation and Alzheimer's disease
2. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
3. A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/Re1A
4. The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-β peptide but not aggregated, cytotoxic amyloid-β peptide
5. Specificity in recognition of amyloid beta-peptide by the serpin-enzyme complex receptor in hepatoma cells and neuronal cells
6. Transforming growth factor-β in disease: The dark side of tissue repair
7. Advanced protein glycosylation in diabetes and aging
8. Perlecan binds to the β-amyloid proteins (Aβ) of Alzheimer's disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability
9. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells
10. Disorders of the extracellular matrix and the pathogenesis of senile dementia of the Alzheimer's type
11. Altered expression of transforming growth factor-β in Alzheimer's disease
12. Transforming growth factor-βs in neurodegenerative disease
13. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils
14. Rodent models of Alzheimer's disease: Rat Aβ infusion approaches to amyloid deposits
15. 1 null mouse phenotype
16. Microglia and the immune pathology of Alzheimer disease
17. Amyloid, the presenilins, and Alzheimer's disease
18. RAGE mediates a novel proinflammatory axis: The cell surface receptor for S100/calgranulin polypeptides
19. Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors
20. Signaling of transforming growth factor-β family members through Smad proteins
21. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2
22. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex
23. Association of apolipoprotein E with murine amyloid A protein amyloid
24. Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice
25. Aβ amyloidogenesis: Unique, or variation on a systemic theme?
26. Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death
27. RAGE at the blood-brain barrier mediates neurovascular dysfunction caused by amyloid-β1-40 peptide
28. Murine models define the role of TGF-β as a master regulator of immune cell function
29. Autoimmunity associated with TGF-β1 deficiency in mice is dependent on MHC class II antigen expression
30. Sp1 binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells
31. Characterization and functional analysis of the promoter of RAGE
32. The myeloid related protien MRP 8/14 (27E10 antigen) usefulness as a potential marker for diease activity in ulcerative colitis and putative biological function
33. Assignment of transforming growth factor β1 and β3 and a third new ligand to the type I receptor ALK-1
34. Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe
35. Transcriptional control by the TGF-β/Smad signaling system
36. The alpha-5 beta-1 integrin receptor binds the Alzheimer disease amyloid-beta protein and mediates its internalization
37. 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation
38. Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κB
39. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
40. Cloning and expression of RAGE: A cell surface receptor for advanced glycosylation end products of proteins
41. Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogensis
42. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor
43. Protective effect of transforming growth factor-β1 on β-amyloid neurotoxicity in rat hippocampal neurons
44. Transforming growth factor-β
45. The S100 family of EF-hand calcium-binding proteins: Functions, and pathology
46. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
47. The dark side of glucose
48. RAGE has a central role in vessel wall interactions, and gene activation in response to AGEs
49. Isolation and characterization of binding protiens for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface
50. Regulation of human mononuclear phagocyte migration by cell surface binding proteins for AGEs
51. The biololgy of RAGE and its ligands
52. Translating cell biology into therapeutic advances in Alzheimer's disease
53. Human brain S100 beta and S100 beta mRNA expression increases with age: Pathogenic implication for Alzheimer's disease
54. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
55. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease
56. An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain
57. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-β binding protein of endothelial and stromal cells
58. Biology and action of colony stimulating factor-1
59. RAGE promotes Aβ-induced cell stress in transgenic mice
60. The gene defects responsible for familial Alzheimer's disease
61. Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium
62. Transforming growth factor beta (TGF-β) in inflammation: A cause and a cure
63. 1-42 binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptors
64. Astroglial overproduction of TGF-β1 enhances inflammatory central nervous system disease in transgenic mice
65. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1
66. Chronic overproduction of TGF-β1 in astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice
67. TGF-β1 promotes microglial amyloid-β clearance, and reduces plaque burden in transgenic mice
68. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and Alzheimer's disease
69. Ibuprofen, inflammation, and Alzheimer disease
70. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis - A possible mechanism for Alzheimer's disease
71. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis
72. RAGE, and amyloid-β peptide neurotoxicity in Alzheimer's disease
73. Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease